Efficient treatment of recurrent hepatitis B complications can save lives and money: NHRI researchers

December 9, 2019 Scientists with Taiwan’s National Health Research Institutes (NHRI) and National Taiwan University Hospital, with the support of the Taiwan Cooperative Oncology Group (TCOG), have determined that prophylactic antiviral therapy for lymphoma patients will be essential to optimizing preventative strategies and the allocation of medical resources. In hepatitis…